Stock Earnings

Question 1

What are Caris Life Sciences Inc's key financial statements?

Accepted Answer

According to the latest financial statement (Form-10K), Caris Life Sciences Inc has a total asset of $343, Net loss of $-378

Question 2

What are the key financial ratios for CAI?

Accepted Answer

Caris Life Sciences Inc's Current ratio is 0.55, has a Net margin is -91.74, sales per share of $1.48.

Question 3

How is Caris Life Sciences Inc's revenue broken down by segment or geography?

Accepted Answer

Caris Life Sciences Inc largest revenue segment is Molecular Profiling Services, at a revenue of 349,115,000 in the most earnings release.For geography, United States is the primary market for Caris Life Sciences Inc, at a revenue of 401,836,000.

Question 4

Is Caris Life Sciences Inc profitable?

Accepted Answer

no, according to the latest financial statements, Caris Life Sciences Inc has a net loss of $-378

Question 5

Does Caris Life Sciences Inc have any liabilities?

Accepted Answer

yes, Caris Life Sciences Inc has liability of 620

Question 6

How many outstanding shares for Caris Life Sciences Inc?

Accepted Answer

Caris Life Sciences Inc has a total outstanding shares of 277.93

Breakdown	TTM	12/31/2024	12/31/2023
Revenue	931	412	306
Revenue Growth (YoY)	--	35%	--
Cost of Revenue	432	231	214
Gross Profit	498	180	91
Selling, General & Admin	615	325	295
Research & Development	183	111	114
Operating Expenses	799	437	410
Other Non Operating Income (Expenses)	0	0	-1
Pretax Income	-431	-281	-341
Income Tax Expense	0	0	0
Net Income	-998	-378	-462
Net Income Growth	--	-18%	--
Shares Outstanding (Diluted)	297.21	277.93	277.93
Shares Change (YoY)	--	0%	--
EPS (Diluted)	-3.35	-1.36	-1.66
EPS Growth	--	-18%	--
Free Cash Flow	-150	-253	-298
Free Cash Flow Per Share	-0.5	-0.91	-1.07
Gross Margin	53.49%	43.68%	29.73%
Operating Margin	-32.22%	-62.37%	-104.24%
Profit Margin	-107.19%	-91.74%	-150.98%
Free Cash Flow Margin	-16.11%	-61.4%	-97.38%
EBITDA	-251	-257	-319
EBITDA Margin	-26.96%	-62.37%	-104.24%
D&A For EBITDA	49	0	0
EBIT	-300	-257	-319
EBIT Margin	-32.22%	-62.37%	-104.24%
Effective Tax Rate	0%	0%	0%

Caris Life Sciences Inc (CAI) Price

CAI Stock Price Chart

CAI Income

Follow-Up Questions